OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints
Andrea Vergallo, Simone Lista, Yuhai Zhao, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs
Ana Rita Monteiro, Daniel José Barbosa, Fernando Remião, et al.
Biochemical Pharmacology (2023) Vol. 211, pp. 115522-115522
Open Access | Times Cited: 113

Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives
Byeong‐Hyeon Kim, Sujin Kim, Yunkwon Nam, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 4

MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities
Nermeen Z. Abuelezz, Fayza Eid Nasr, Mohammad A. Abdulkader, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 42

MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
Ivana Raffaele, Serena Silvestro, Emanuela Mazzon
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4736-4736
Open Access | Times Cited: 21

The Role of miR-128 in Neurodegenerative Diseases
Marika Lanza, Salvatore Cuzzocrea, Salvatore Oddo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6024-6024
Open Access | Times Cited: 13

Hallmarks of aging and Alzheimer’s Disease pathogenesis: paving the route for new therapeutic targets
Federico Bellelli, Davide Angioni, Beatrice Arosio, et al.
Ageing Research Reviews (2025) Vol. 106, pp. 102699-102699
Closed Access

Focus on the Complex Interconnection between Cancer, Narcolepsy and Other Neurodegenerative Diseases: A Possible Case of Orexin-Dependent Inverse Comorbidity
Maria P. Mogavero, Alessandro Silvani, Lourdes M. DelRosso, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2612-2612
Open Access | Times Cited: 28

Biomarker profiling to determine clinical impact of microRNAs in cognitive disorders
Weijie Zhai, Meng Zhao, Chunxiao Wei, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

A Review of Clinical Biomarker Insights: Advances in Diagnosis and Prognosis of Early Alzheimer
Ramanathan Rajagopalan, S. Hariharan, N.R. Akshaya, et al.
Global Journal of Medical Pharmaceutical and Biomedical Update (2025) Vol. 20, pp. 5-5
Closed Access

Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort study
Farnoosh Usefi, Auob Rustamzadeh, Zahra Ghobadi, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 6, pp. 1201-1211
Closed Access | Times Cited: 3

Exploring the impact of miR-128 in inflammatory diseases: A comprehensive study on autoimmune diseases
Ria Margiana, Hamzah H. Kzar, Fadhil Hussam, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154705-154705
Open Access | Times Cited: 8

MicroRNA-Target Interaction Regulatory Network in Alzheimer’s Disease
Aleksander Turk, Tanja Kunej, Borut Peterlin
Journal of Personalized Medicine (2021) Vol. 11, Iss. 12, pp. 1275-1275
Open Access | Times Cited: 17

Self- and Partner-Reported Subjective Memory Complaints: Association with Objective Cognitive Impairment and Risk of Decline
Leah Zuroff, Laura E.M. Wisse, Trevor Glenn, et al.
Journal of Alzheimer s Disease Reports (2022) Vol. 6, Iss. 1, pp. 411-430
Open Access | Times Cited: 9

Chromatin Remodeling Factor SMARCA5 is Essential for Hippocampal Memory Maintenance via Metabolic Pathways in Mice
Yu Qu, Nan Zhou, Xia Zhang, et al.
Neuroscience Bulletin (2023) Vol. 39, Iss. 7, pp. 1087-1104
Open Access | Times Cited: 5

miR-128 as a Regulator of Synaptic Properties in 5xFAD Mice Hippocampal Neurons
Inna Shvarts-Serebro, Anton Sheinin, Irit Gottfried, et al.
Journal of Molecular Neuroscience (2021) Vol. 71, Iss. 12, pp. 2593-2607
Closed Access | Times Cited: 11

Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s Disease
Nidhi Puranik, Minseok Song
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9936-9936
Open Access | Times Cited: 1

Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway Model
Harald Hampel, Simone Lista, Giuseppe Caruso, et al.
Current Neuropharmacology (2021) Vol. 21, Iss. 1, pp. 31-53
Open Access | Times Cited: 4

Exploring the versatility of miRNA-128: a comprehensive review on its role as a biomarker and therapeutic target in clinical pathways
Dipa K. Israni, M. Patel, Rohinee K. Dodiya
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access

Advances in radiopharmaceuticals for precision medicine: A global and Chinese perspective
Qingqing Huang, Gang Huang
LabMed discovery. (2024), pp. 100031-100031
Open Access

Exploring the role of miR-125b-5p as a pro-inflammatory factor in Alzheimer's disease pathology
Wenjia Liu, Sophia Chen, Xin Rao, et al.
Journal of Alzheimer s Disease (2024)
Closed Access

A Review on the Correlation between the Pathology of Alzheimer's Disease and microRNA
Soo-Jung Kim, Hyun‐Jeong Cho
Journal of Experimental & Biomedical Sciences/Biomedical Science Letters (2021) Vol. 27, Iss. 4, pp. 208-215
Open Access

Page 1

Scroll to top